tiprankstipranks
GeneDx Holdings (WGS)
NASDAQ:WGS
US Market
WGS
GeneDx Holdings
RESEARCH TOOLSreports

GeneDx Holdings (WGS) Income Statement

922 Followers

GeneDx Holdings Income Statement

Last quarter (Q4 2025), GeneDx Holdings's total revenue was $120.99M, an increase of 26.50% from the same quarter last year. In Q4, GeneDx Holdings's net income was $-17.67M. See GeneDx Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 427.54M$ 305.45M$ 202.57M$ 234.69M$ 212.19M
Gross Profit
$ 298.17M$ 194.40M$ 90.01M$ -26.75M$ -16.60M
Operating Expenses
$ 311.25M$ 217.61M$ 270.60M$ 640.90M$ 429.55M
Depreciation and Amortization
$ 25.22M$ 21.95M$ 33.73M$ 59.31M$ 21.81M
EBITDA
$ 6.63M$ -1.26M$ -136.46M$ -398.20M$ -220.75M
Operating Income
$ -11.80M$ -23.21M$ -180.60M$ -667.65M$ -446.15M
Other Income/Expenses
$ -9.34M$ -29.42M$ 3.90M$ 69.62M$ 200.76M
Pretax Income
$ -21.14M$ -52.63M$ -176.69M$ -598.03M$ -245.39M
Net Income
$ -21.02M$ -52.29M$ -175.77M$ -548.98M$ -245.39M
Per Share Metrics
Basic EPS
$ -0.73$ -1.94$ -7.23$ -53.63$ -74.93
Diluted EPS
$ -0.73$ -1.94$ -7.23$ -53.63$ -74.93
Weighted Average Shares Outstanding
 26.89M 26.89M 24.31M 10.24M 3.28M
Weighted Average Shares Outstanding (Diluted)
 26.89M 26.89M 24.31M 10.24M 3.28M
Currency in USD

GeneDx Holdings Earnings and Revenue History